Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
31.78B | 18.41B | 17.35B | 21.50B | 16.43B | 12.14B | Gross Profit |
11.79B | 7.25B | 6.68B | 7.89B | 5.93B | 4.42B | EBIT |
4.12B | 3.06B | 2.51B | 2.89B | 2.45B | 2.26B | EBITDA |
3.46B | 3.64B | 3.20B | 3.58B | 2.95B | 2.66B | Net Income Common Stockholders |
3.42B | 2.30B | 1.91B | 2.25B | 1.92B | 1.64B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.52B | 3.52B | 4.08B | 3.22B | 3.67B | 2.23B | Total Assets |
19.81B | 19.81B | 19.64B | 20.52B | 17.44B | 13.21B | Total Debt |
4.33B | 4.33B | 4.40B | 4.61B | 3.64B | 4.04B | Net Debt |
1.05B | 1.05B | 661.19M | 1.78B | 1.23B | 2.02B | Total Liabilities |
6.73B | 6.73B | 7.11B | 7.77B | 6.03B | 5.98B | Stockholders Equity |
12.08B | 12.08B | 11.56B | 11.71B | 10.74B | 6.70B |
Cash Flow | Free Cash Flow | ||||
1.11B | 985.45M | 2.50B | 363.28M | 492.23M | 1.84B | Operating Cash Flow |
4.00B | 2.55B | 4.06B | 2.32B | 1.92B | 2.68B | Investing Cash Flow |
-2.51B | -1.54B | -1.66B | -1.10B | -2.72B | -686.30M | Financing Cash Flow |
-1.43B | -1.28B | -1.33B | -844.19M | 1.11B | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $1.70B | 14.29 | 12.40% | 1.97% | 1.81% | 8.09% | |
73 Outperform | $2.39B | 8.14 | 18.95% | 5.43% | 4.82% | 19.01% | |
60 Neutral | $1.16B | ― | -50.58% | 7.08% | -7.28% | -272.76% | |
60 Neutral | $13.01B | 10.45 | 0.79% | 3.53% | 1.60% | -22.47% | |
52 Neutral | $2.08B | 15.65 | 17.42% | 2.93% | 3.80% | 182.70% | |
47 Neutral | $137.95M | ― | -4.47% | 7.42% | -16.67% | -24.91% | |
41 Neutral | $169.35M | ― | 9.10% | ― | -11.28% | -1004.59% |